Table 1.
Author | Method | Cohort | Cohort Size (n) | Outcome |
---|---|---|---|---|
[21] | Agilent SureSelect Human & Illumina sequencing | Autosomal dominant EOAD without known mutations | 14 | 7 unknown mutations detected in SORL1 gene. |
[20] | WGS, Illumina bead chip, and imputation | Icelandic | 1795 WGS 71743 chip |
Coding mutation A673T in APP protects against AD. |
[16] | WGS, Illumina bead chip, and imputation | Icelandic | 1795 WGS | rs75932628-T (R47H) of TREM2 increases risk of LOAD. |
[17] | Illumina WES TruSeq, Illumina Sequenced | Caucasian from UK, US and Canada | 1092 AD cases 1107 Controls |
rs75932628-T (R47H) of TREM2 increases risk of LOAD. |
[14] | Roche NimbleGen v2 and v3, SeqCap® EZ Exome, Illumina TruSeq | 1908 Dutch AD cases and Controls | 640 cases 1268 Controls |
181 unique SORL1 variants detected. Developed a strategy to classify SORL1 variants into five subtypes ranging from pathogenic to benign. |
[22] | Targeted sequencing using Agilent HaloPLex™ and Illumina sequencing | Unrelated LOAD and matched controls | 772 LOAD 757 Controls |
Intronic variant rs78117248 in ABCA7 showed strongest association with AD. Loss of function mutations may be a potential pathogenic mechanism. |
[18] | WGS and WES data generated by ADSP using Roche NimbleGen and Illumina Rapid Capture Exome | European-American and Hispanic | 172 AD 171 Controls |
Novel variants in previously reported AD risk genes and variants in novel genes IGHG3 and ZNF655 were detected. |
[19] | Agilent SureSelect and ADSP using Roche NimbleGen and Illumina Rapid Capture Exome | Caucasian non APOE*4 carriers from PITT-ADRC 1 ADSP 2 |
PITT-ADRC1372 AD 348 Controls ADSP2 2113 AD 5139 Controls |
Association at novel variant in NSF gene and known loci in TREM2, TOMM40 and APOE was detected. |
[15] | Roche NimbleGen, Agilent NextEra, Truseq, HaloPlex, SureSelect, Illumina Nextera® Rapid Capture Exome | 25982 Caucasian | 12652 AD 8693 controls |
Detected protein damaging variants in TREM2, SORL1 and ABCA7 and protective variants in CBX3 and PRSS3. |
[23] | ADSP using Nimblegen NimbleGen v2 and v3 and Illumina Nextera® Rapid Capture Exome | 5142 | 4889 | Identified a VNTR within MUC6 associated with pTau burden. |
1: University of Pittsburgh Alzheimer’s Disease Research Center (ADRC). 2: Alzheimer’s Disease Sequencing Project (ADSP).